Cross Country Healthcare gains on report it likely won't be subject of FTC meeting
2025-07-31 12:20:42 ET
More on Cross Country Healthcare
- Cross Country Healthcare: At This Price, The Pending Acquisition Is Worth Betting On (Rating Upgrade)
- Cross Country Healthcare drops amid news of FTC meeting next week
- Seeking Alpha’s Quant Rating on Cross Country Healthcare
- Historical earnings data for Cross Country Healthcare
- Financial information for Cross Country Healthcare
Read the full article on Seeking Alpha
For further details see:
Cross Country Healthcare gains on report it likely won't be subject of FTC meetingNASDAQ: CCRN
CCRN Trading
-3.07% G/L:
$9.305 Last:
155,309 Volume:
$9.66 Open:



